Nintedanib for treating fibrosing interstitial lung disease in people aged 6 to 17 [ID6194]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Inhaled treprostinil for treating pulmonary hypertension caused by interstitial lung disease ID6459Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC